(Press-News.org) New research showing how the HIV virus targets "veterans" or memory T-cells could change how drugs are used to stop the virus, according to new research by George Mason University.
The research will appear in the Journal of Biological Chemistry's October edition and currently is available online.
"It's a big breakthrough for us," says Yuntao Wu, an author of the study and professor at the Mason-based National Center for Biodefense and Infectious Diseases. "I think this will impact the field."
Helper T-cells support the body's immune system by organizing forces to fight off infection. The HIV virus hijacks helper T-cells. When helper T-cell numbers plummet, the body is vulnerable to disease.
Not all helper T-cells are the same; some are experienced ones called memory helper T-cells, and others, naive cells or "virgin" cells, haven't encountered an infection. Mason researchers studied why HIV preferentially goes after memory helper T-cells, while shunning their close colleagues. Memory and naive T-cells appear similar.
"In the body, HIV is able to kill most memory helper cells," says Weifeng Wang, the study's main author. "We wanted to pursue what makes the difference between memory and naive T-cells on a molecular level."
Unlike naive helper T-cells, memory T-cells are on the go, and much more mobile. And it's that momentum that attracts the HIV virus and makes the memory cell vulnerable, says Wang, who's currently a research fellow in the Dana-Farber Cancer Institute at Harvard Medical School.
When a memory cell moves, inside the cell, it looks like a waterfall on the moving edge. "It's called 'treadmilling'," Wu says. "The cytoskeleton or the cell's supporting bone is acting like a muscle. The treadmilling of cytoskeleton pushes the cell to migrate. That's how it pushes itself. In the past year we've been studying how HIV infects those memory cells. It has to go to the center, into the nucleus. It has to go past the cytoskeleton barriers to go into the center. For many years we didn't understand how the virus could cross such a structure. It's like a wall. It has to cross that wall."
HIV jumps over the wall by exploiting the cell's treadmilling process, Wu says. "The HIV virus uses a receptor to attach to the cell for entry," he says. "When the virus touches that receptor it's like someone ringing the doorbell. That triggers a signal — someone comes out and opens the door. Now the HIV virus can start the treadmill to 'walk' along the cytoskeleton towards the center. If the virus goes to naive cells, it cannot do it. Naive cells aren't sensitive enough. The cytoskeleton of these 'virgin' cells is different from the memory cells, and it is not easy for the virus to start the treadmilling process."
HIV's knack for mutating makes it a tough target for drugs, Wang says. By shifting the focus to the cell, away from the virus itself, researchers may find a new way to tackle the virus, he says.
"Basically, our new strategy will be finding a cellular target, something HIV needs to depend on," Wu says. "It's as if the virus says 'give me a house.' The cell is the house. The house has to have electricity and everything so it can live there. Our approach is to look for something the virus needs to live in that house and then to reduce it or shut it down. The challenge will be if you shut that down, that it doesn't impact normal cell functions. It's a very tricky balance. You want to kill the virus but not healthy cells along with it."
Wu is looking at existing drugs, including those used for cancer. "There is something shared between cancer cells and HIV-infected cells because cancer cells also like to migrate. So some drugs that are used to slow down cancer migration could also be used to treat HIV."
###NYC DC AIDS Research Ride partially funded the research for three years, Wu says. Also, a $1.2 million grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, is funding the project from June 2009 until May 2013.
For more information, please contact Michele McDonald at
mmcdon15@gmu.edu or (703) 993-8781.
About George Mason University
George Mason University is an innovative, entrepreneurial institution with global distinction in a range of academic fields. Located in Northern Virginia near Washington, D.C., Mason provides students access to diverse cultural experiences and the most sought-after internships and employers in the country. Mason offers strong undergraduate and graduate degree programs in engineering and information technology, organizational psychology, health care and visual and performing arts. With Mason professors conducting groundbreaking research in areas such as climate change, public policy and the biosciences, George Mason University is a leading example of the modern, public university. George Mason University—Where Innovation Is Tradition.
Research breakthrough opens door to new strategy for battling HIV
Memory T-cells targeted
2012-09-26
ELSE PRESS RELEASES FROM THIS DATE:
As population, interest in outdoor recreation grow, more pressure likely for northern forests
2012-09-26
NEWTOWN SQUARE, Penn., September 26, 2012 – Despite just modest gains in population and participation in outdoor recreation compared to the rest of the nation, there is a strong likelihood of increasing pressure on forest and other undeveloped lands in northern states as the population grows and recreation demands shift.
"Outdoor Recreation in the Northern United States," a report recently published by the U.S. Forest Service's Northern Research Station as GTR NRS-100, evaluates recent population trends and forecasts within the context of other U.S. regions, demographic ...
Change in treatment regime for cryptococcal meningitis may be needed
2012-09-26
The most cost-effective treatment for cryptococcal meningitis (a serious infection of the brain membranes, usually in people with AIDS or other immune system deficiencies) is different to that currently recommended by the World Health Organization (WHO), warranting a review of policy, according to the findings of a study published in this week's PLOS Medicine.
Researchers from Makerere University in Kampala, Uganda, and from the University of Minnesota in the US found that a short (7-day) course of amphotericin along with high-dose fluconazole for at least 2 weeks is ...
Large donors are forcing the World Health Organization to reform
2012-09-26
The current practice of large donors is forcing the World Health Organization and the World Bank to reflect on how to reform to remain more appealing to the wider set of stakeholders and interests at play, according to Devi Sridhar from the University of Oxford writing in this week's PLOS Medicine.
Sridhar argues that since the priorities of funding bodies largely dictate what health issues and diseases are studied, a major challenge in the governance of global health research funding is agenda-setting, which in turn is a consequence of a larger phenomenon—"multi-bi ...
PLOS Medicine editors comment on progress of World Health Report 2012
2012-09-26
In this month's editorial, the PLOS Medicine Editors comment on the World Health Organization's (WHO) latest World Health Report, originally planned for publication in 2012, and the outcomes of the journal's collaboration with WHO on the intended theme of "no health without research." As part of that collaboration, the journal editors and WHO previously called for submission of papers to a joint collection on that theme, inviting "the submission of articles, especially from low- and middle-income countries, on topics related to the strengthening of key functions and components ...
Study examines usage, outcomes of knee replacement procedures among Medicare patients
2012-09-26
CHICAGO – There has been an increase in total knee arthroplasty (TKA; knee replacement) procedures over the past 20 years that has been driven by both an increase in the number of Medicare enrollees and increase in per capita utilization, according to a study in the September 26 issue of JAMA. There has also been a decrease in hospital length of stay for TKA, but increased hospital readmission rates and increased rates of infectious complications.
"Total knee arthroplasty is a common and safe procedure typically performed for relief of symptoms in patients with severe ...
Using corticosteroid for children undergoing tonsillectomy may not increase risk of serious bleeding
2012-09-26
CHICAGO – Administration of the corticosteroid dexamethasone to children during a tonsillectomy was not associated with excessive, serious bleeding events following surgery compared to patients who received placebo, according to a study in the September 26 issue of JAMA.
Tonsillectomy is exceedingly common, with a reported increase in tonsillectomy rates in children younger than 15 years from 287,000 to 530,000 per year over the past decade. Although safe, adenotonsillectomy can result in significant complications, according to background information in the article. ...
Pre-op steroids to prevent nausea do not significantly increase post-op bleeding
2012-09-26
Boston (Sept. 25, 2012) — Tonsillectomy is exceedingly common, with a reported increase in tonsillectomy rates in children younger than 15 years from 287,000 to 530,000 per year over the past decade. Although safe, adenotonsillectomy can result in significant complications, such as aspiration and bleeding. Complications are infrequent, but because tonsillectomy is so common, the absolute number of children experiencing tonsillectomy complications is formidable.
Corticosteroids are often given to children undergoing tonsillectomy to reduce postoperative nausea and vomiting; ...
Most European languages in danger of digital extinction
2012-09-26
Scientists from The University of Manchester were part of a European team of researchers who concluded that digital assistance for 21 of the 30 languages investigated is 'non-existent' or 'weak' at best.
The report coincides with the European Day of Languages [SEPTEMBER 26], a day which recognises the importance of fostering and developing the rich linguistic and cultural heritage of our continent.
Languages spoken by a small number of people could be at risk because they do not have technological support, the report by META-NET, a European network of excellence that ...
Future health risks for obese children may be greater than previously thought
2012-09-26
Research: Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis
Editorial: Obesity in children and adolescents
Being obese as a child or adolescent may have a larger effect on future health than previously thought, suggests a study published on bmj.com today.
It comes as New York City passes a ban on large-size sugary drinks to help tackle obesity and related health problems in the US. MPs are now calling on the government to introduce similar legislation in the UK.
Researchers at the University ...
Should celebrities get involved in public health campaigns?
2012-09-26
Simon Chapman, Professor of Public Health at the University of Sydney thinks the extra publicity that celebrities provide can help promote public health. He acknowledges that celebrities are not experts but says, unlike many experts, they "often speak personally and bring compelling authenticity to public discourse."
He says those concerned about celebrities in health campaigns "invariably point to examples which have gone badly wrong or which fail to change the world forever" but argues "they are silent about the many examples of celebrity engagement that have massively ...
LAST 30 PRESS RELEASES:
Fig trees convert atmospheric CO2 to stone
Intra-arterial tenecteplase for acute stroke after successful endovascular therapy
Study reveals beneficial microbes that can sustain yields in unfertilized fields
Robotic probe quickly measures key properties of new materials
Climate change cuts milk production, even when farmers cool their cows
Frozen, but not sealed: Arctic Ocean remained open to life during ice ages
Some like it cold: Cryorhodopsins
Demystifying gut bacteria with AI
Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads
Unlocking the hidden biodiversity of Europe’s villages
Planned hydrogen refuelling stations may lead to millions of euros in yearly losses
Planned C-sections increase the risk of certain childhood cancers
Adults who have survived childhood cancer are at increased risk of severe COVID-19
Drones reveal extreme coral mortality after bleaching
New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia
Native habitats hold the key to the much-loved smashed avocado’s future
Using lightning to make ammonia out of thin air
Machine learning potential-driven insights into pH-dependent CO₂ reduction
Physician associates provide safe care for diagnosed patients when directly supervised by a doctor
How game-play with robots can bring out their human side
Asthma: patient expectations influence the course of the disease
UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery
New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis
XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion
Flexible, eco-friendly electronic plastic for wearable tech, sensors
Can the Large Hadron Collider snap string theory?
Stuckeman professor’s new book explores ‘socially sustainable’ architecture
Synthetic DNA nanoparticles for gene therapy
New model to find treatments for an aggressive blood cancer
Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support
[Press-News.org] Research breakthrough opens door to new strategy for battling HIVMemory T-cells targeted